Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04846920
Title A Study of Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications

renal cell carcinoma

Therapies

Belzutifan

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Beth Israel Deaconess Medical Center ( Site 1002) Recruiting Boston Massachusetts 02215 United States Details
University of Michigan ( Site 1006) Recruiting Ann Arbor Michigan 48109 United States Details
Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 1005) Recruiting Nashville Tennessee 37232 United States Details
University of Texas MD Anderson Cancer Center-Genitourinary Medical Oncology ( Site 1007) Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field